Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. GVK Biosciences Pvt. Ltd.
EIR
•GVK Biosciences Pvt. Ltd.•October 9, 2014

GVK Biosciences Pvt. Ltd. – FDA EIR, Oct 9, 2014

Record Details

An FDA inspection of Clinogent (A Division of GVK Biosciences Pvt. Ltd.) in Hyderabad, India, was conducted from September 29 to October 9, 2014. The inspection, which also included representatives from the European Medicines Agency, identified significant deficiencies in the company's adherence to regulatory frameworks concerning study conduct and record integrity.

Key violations included a failure to maintain accurate study records, such as discrepancies between centrifugation and freezing times for samples. A major concern was the lack of control and reconciliation of quality assurance (QA) issued study records, with unarchived forms and raw data from previous years found unsecured. Furthermore, the Ethics Committee had not reviewed or approved study-specific informed consent forms that included handwritten additional screening procedures, leading to inconsistent information provided to volunteers. Other issues noted were unsecured access to critical laboratory and archival areas, and the absence of a Standard Operating Procedure for the use of "extra" study subjects.

These observations highlight the need for Clinogent to implement robust corrective and preventive actions to ensure compliance with good clinical and laboratory practices, enhance data integrity, and strengthen their quality management system, particularly regarding document control and informed consent processes, in accordance with applicable regulatory guidelines.

Company
GVK Biosciences Pvt. Ltd.
Inspection date
October 9, 2014
Product type
drugs
Office
Office of Compliance
People
  • Vivek Vardhen Tummala (company_representative)
  • Ramesh Gambhir (company_representative)
  • V. Kishan Prasad (company_representative)
  • Manni Kantipudi (company_representative)
  • C.H. Nagaratham (company_representative)
View Company Profile

ID · e8a83dcb-d2d7-4e8b-89e7-85656fd65f9f

Violation Codes3
21 CFR 50.27(a)21 CFR 32021 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for GVK Biosciences Pvt. Ltd.
  • 483 - 2015-03-13March 13, 2015
  • EIR - 2015-03-13March 13, 2015
  • 483 - 2014-10-09October 9, 2014
  • EIR - 2011-03-30March 30, 2011
  • 483

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore GVK Biosciences Pvt. Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.